Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Traws Pharma (TRAW) Restructuring Costs (2024 - 2025)

Traws Pharma (TRAW) has disclosed Restructuring Costs for 2 consecutive years, with $889000.0 as the latest value for Q4 2025.

  • For Q4 2025, Restructuring Costs fell 8.35% year-over-year to $889000.0; the TTM value through Dec 2025 reached $3.8 million, down 29.66%, while the annual FY2025 figure was $2.6 million, 21.48% down from the prior year.
  • Restructuring Costs hit $889000.0 in Q4 2025 for Traws Pharma, up from $499000.0 in the prior quarter.
  • Across five years, Restructuring Costs topped out at $2.6 million in Q1 2024 and bottomed at $499000.0 in Q3 2025.